SEARCH

SEARCH BY CITATION

References

  • Abbadie C. and Pasternak G. W. (2001) Differential in vivo internalization of MOR-1 and MOR-1C by morphine. NeuroReport 12, 30693072.
  • Abbadie C., Gultekin S. H. and Pasternak G. W. (2000a) Immunohistochemical localization of the carboxy terminus of the novel mu opioid receptor splice variant MOR-1C within the human spinal cord. NeuroReport 11, 19531957.
  • Abbadie C., Pan Y., Drake C. T. and Pasternak G. W. (2000b) Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS. Neuroscience 100, 141153.
  • Abbadie C., Pan Y. X. and Pasternak G. W. (2000c) Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-1C-like and MOR-1-like immunoreactivity: evidence for region-specific processing. J. Comp. Neurol. 419, 244256.
  • Barrett A. C., Smith E. S. and Picker M. J. (2002) Sex-related differences in mechanical nociception and antinociception produced by mu- and kappa-opioid receptor agonists in rats. Eur. J. Pharmacol. 452, 163173.
  • Bolan E. A., Pan Y. X. and Pasternak G. W. (2004) Functional analysis of MOR-1 splice variants of the mouse mu opioid receptor gene Oprm. Synapse 51, 1118.
  • Boyer J. S., Morgan M. M. and Craft R. M. (1998) Microinjection of morphine into the rostral ventromedial medulla produces greater antinociception in male compared to female rats. Brain Res. 796, 315318.
  • Chakrabarti S., Liu N. J. and Gintzler A. R. (2010) Formation of mu-/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia. Proc. Natl Acad. Sci. USA 107, 2011520119.
  • Chakrabarti S., Liu N. J., Zadina J. E., Sharma T. and Gintzler A. (2012) Pleiotropic opioid regulation of spinal endomorphin 2 release and its adaptations to opioid withdrawal are sexually dimorphic. J. Pharmacol. Exp. Ther. 340, 5663.
  • Chen Y., Mestek A., Liu J., Hurley J. A. and Yu L. (1993) Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol. Pharmacol. 44, 812.
  • Cicero T. J., Nock B. and Meyer E. R. (1996) Gender-related differences in the antinociceptive properties of morphine. J. Pharmacol. Exp. Ther. 279, 767773.
  • Cicero T. J., Nock B. and Meyer E. R. (1997) Sex-related differences in morphine's antinociceptive activity: relationship to serum and brain morphine concentrations. J. Pharmacol. Exp. Ther. 282, 939944.
  • Cook C. D., Barrett A. C., Roach E. L., Bowman J. R. and Picker M. J. (2000) Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor. Psychopharmacology 150, 430442.
  • Craft R. M., Stratmann J. A., Bartok R. E., Walpole T. I. and King S. J. (1999) Sex differences in development of morphine tolerance and dependence in the rat. Psychopharmacology 143, 17.
  • Holtman J. R., Jr, Sloan J. W. and Wala E. P. (2004) Morphine tolerance in male and female rats. Pharmacol. Biochem. Behav. 77, 517523.
  • Hosseini M., Karami R., Khodabandeloo F. and Khatami L. (2010) Gender dependent differences Iin analgesic effect and tolerance to morphine. Pharmacologyonline 3, 92101.
  • Kahsai A. W., Xiao K., Rajagopal S., Ahn S., Shukla A. K., Sun J., Oas T. G. and Lefkowitz R. J. (2011) Multiple ligand-specific conformations of the beta2-adrenergic receptor. Nat. Chem. Biol. 7, 692700.
  • Kest B., Palmese C. and Hopkins E. (2000) A comparison of morphine analgesic tolerance in male and female mice. Brain Res. 879, 1722.
  • Koch T., Schulz S., Schroder H., Wolf R., Raulf E. and Hollt V. (1998) Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. J. Biol. Chem. 273, 1365213657.
  • Koch T., Schulz S., Pfeiffer M., Klutzny M., Schroder H., Kahl E. and Hollt V. (2001) C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization. J. Biol. Chem. 276, 3140831414.
  • Krzanowska E. K. and Bodnar R. J. (1999) Morphine antinociception elicited from the ventrolateral periaqueductal gray is sensitive to sex and gonadectomy differences in rats. Brain Res. 821, 224230.
  • Lefkowitz R. J., Pierce K. L. and Luttrell L. M. (2002) Dancing with different partners: protein kinase A phosphorylation of seven membrane-spanning receptors regulates their G protein-coupling specificity. Mol. Pharmacol. 62, 971974.
  • Liu N. J., Chakrabarti S., Schnell S., Wessendorf M. and Gintzler A. R. (2011) Spinal synthesis of estrogen and concomitant signaling by membrane estrogen receptors regulate spinal κ- and μ-opioid receptor heterodimerization and female-specific spinal morphine antinociception. J. Neurosci. 31, 1183611845.
  • Livak K. J. and Schmittgen T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402408.
  • Madia P. A., Navani D. M. and Yoburn B. C. (2012) [(35)S]GTPgammaS binding and opioid tolerance and efficacy in mouse spinal cord. Pharmacol. Biochem. Behav. 101, 155165.
  • Martin-Schild S., Gerall A. A., Kastin A. J. and Zadina J. E. (1999) Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J. Comp. Neurol. 405, 450471.
  • Mons N. and Cooper D. M. F. (1994) Adenylyl cyclase mRNA expression does not reflect the predominant Ca2+/calmodulin-stimulated activity in the hypothalamus. J. Neuroendocrinol. 6, 665671.
  • Muranyi M., Cinar R., Kekesi O. et al. (2013) Ligand-specific regulation of the endogenous mu-opioid receptor by chronic treatment with mu-opioid peptide agonists. Biomed Res. Int. 2013, 501086.
  • Pan Y. X. (2005) Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol. 24, 736750.
  • Pan L., Xu J., Yu R., Xu M. M., Pan Y. X. and Pasternak G. W. (2005a) Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm. Neuroscience 133, 209220.
  • Pan Y. X., Xu J., Bolan E., Moskowitz H. S., Xu M. and Pasternak G. W. (2005b) Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Mol. Pharmacol. 68, 866875.
  • Pan Y. X., Xu J., Xu M., Rossi G. C., Matulonis J. E. and Pasternak G. W. (2009) Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions. Proc. Natl Acad. Sci. USA 106, 49174922.
  • Pasternak G. W. (2001) Incomplete cross tolerance and multiple mu opioid peptide receptors. Trends Pharmacol. Sci. 22, 6770.
  • Pasternak W. and Pan Y.-X. (2013) Mu opioids and their receptors: Evolution of a concept. Pharmacol. Rev. 65, 12571317.
  • Pasternak D. A., Pan L., Xu J., Yu R., Xu M. M., Pasternak G. W. and Pan Y. X. (2004) Identification of three new alternatively spliced variants of the rat mu opioid receptor gene: dissociation of affinity and efficacy. J. Neurochem. 91, 881890.
  • Peckham E. M. and Traynor J. R. (2006) Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats. J. Pharmacol. Exp. Ther. 316, 11951201.
  • Sarton E., Olofsen E., Romberg R., den Hartigh J., Kest B., Nieuwenhuijs D., Burm A., Teppema L. and Dahan A. (2000) Sex differences in morphine analgesia: an experimental study in healthy volunteers. Anesthesiology 93, 12451254; discussion 1246A.
  • Schreff M., Schulz S., Wiborny D. and Hollt V. (1998) Immunofluorescent identification of endomorphin-2-containing nerve fibers and terminals in the rat brain and spinal cord. NeuroReport 9, 10311034.
  • Schuller A. G., King M. A., Zhang J. et al. (1999) Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat. Neurosci. 2, 151156.
  • Sternini C., Spann M., Anton B., Keith D. E., Bunnett N. W., von Zastrow M., Evans C. J. and Brecha N. C. (1996) Agonist-selective endocytosis of m-opioid receptor by neurons in vivo. Proc. Natl Acad. Sci. USA 93, 92419246.
  • Villar V. M. and Bhargava H. N. (1992) Pharmacodynamics and kinetics of loss of tolerance and physical dependence on morphine induced by pellet implantation in the rat. Pharmacology 45, 319328.
  • Wolozin B. L. and Pasternak G. W. (1981) Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc. Natl Acad. Sci. USA 78, 61816185.
  • Zamah A. M., Delahunty M., Luttrell L. M. and Lefkowitz R. J. (2002) Protein kinase A-mediated phosphorylation of the beta 2-adrenergic receptor regulates its coupling to Gs and Gi. Demonstration in a reconstituted system. J. Biol. Chem. 277, 3124931256.
  • Zimprich A., Simon T. and Hollt V. (1995) Cloning and expression of an isoform of the rat mu opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1. FEBS Lett. 359, 142146.